Duori Pharmaceuticals: Wang Qingtai and Cao Xiaobing plan to acquire 24.30% of shares through a partial tender offer

2026-02-20 05:04:20

Dory Pharmaceuticals Announcement: Wang Qingtai and Cao Xiaobing plan to make a partial offer at a price of 32.07 yuan per share to all shareholders of Dory Pharmaceuticals except Cui Zihao, to acquire 24.30% of the listed company’s shares. Wang Qingtai and Cao Xiaobing’s preliminary offer proportions are approximately 22% and 2.30%, respectively.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.